Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Individualized Treatment Strategy for Depressive Disorder.

Advances in experimental medicine and biology - 1 Jan 2019

Chen Jun, Hu Shaohua

Abstract excerpt

The goal of treatment for depressive disorders is complete remission of depressive symptoms with full recovery of social function and prevention of recurrence. However, a large proportion of patients do not experience symptomatic remission after the initial treatment, with even lower rates of remission in the longer treatment term. The main objective of individualized treatment applied in psychiatry is to improve...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Depressive Disorder
Share to Epigenomics

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Phenotype

Share to Precision Medicine

Share to Psychiatry

Source

Identifiers

PMID: 31784966
DOI: 10.1007/978-981-32-9271-0_12

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Individualized Treatment Strategy for Depressive Disorder.PMID 31784966Read ↗

Personalized medicine in psychiatry: problems and promises.Semantic proximity Read ↗

The MAKE Biomarker Discovery for Enhancing anTidepressant Treatment Effect and Response Study: Design and MethodologySemantic proximity Read ↗

Advancing Depression Management Through Biomarker Discovery with a Focus on Genetic and Epigenetic Aspects: A Comprehensive Study on Neurobiological, Neuroendocrine, Metabolic, and Inflammatory PathwaysSemantic proximity Read ↗

Treatment-resistant depression: molecular mechanisms and managementSemantic proximity Read ↗

International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets.Semantic proximity Read ↗

Advances in biomarkers of major depressive disorder.Semantic proximity Read ↗

Dissection of the clinical phenome of major depressive disorder into subdomains and subgroups in relation to activated immune-inflammatory profilesSemantic proximity Read ↗

Are there meaningful biomarkers of treatment response for depression?Semantic proximity Read ↗

Genetic Markers for Later Remission in Response to Early Improvement of Antidepressants.Semantic proximity Read ↗

Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses.Semantic proximity Read ↗

Reviewing the genetics of heterogeneity in depression: operationalizations, manifestations and etiologies.Semantic proximity Read ↗

Epigenetic Modulation of Mood DisordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.